Literature DB >> 32623399

Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Harpreet Kaur1, Svetlana Golovko1, Mikhail Y Golovko1, Surjeet Singh2, Diane C Darland3, Colin K Combs1.   

Abstract

BACKGROUND: The intestinal microbiota and its metabolites, particularly short-chain fatty acids (SCFAs), have been implicated in immune function, host metabolism, and even behavior.
OBJECTIVE: This study was performed to investigate whether probiotic administration influences levels of intestinal microbiota and their metabolites in a fashion that may attenuate brain changes in a mouse model of Alzheimer's disease (AD).
METHODS: C57BL/6 wild-type (WT) mice were compared to AppNL-G-Fmice. The animals were treated with either vehicle or probiotic (VSL#3) for 8 weeks. Fecal microbiome analysis along with Aβ, GFAP, Iba-1, c-Fos, and Ki-67 immunohistochemistry was done. SCFAs were analyzed in serum and brains using UPLC-MS/MS.
RESULTS: Probiotic (VSL#3) supplementation for 2 months resulted in altered microbiota in both WT and AppNL-G-Fmice. An increase in serum SCFAs acetate, butyrate, and lactate were found in both genotypes following VSL#3 treatment. Propionate and isobutyrate were only increased in AppNL-G-Fmice. Surprisingly, VSL#3 only increased lactate and acetate in brains of AppNL-G-Fmice. No significant differences were observed between vehicle and VSL#3 fed AppNL-G-Fhippocampal immunoreactivities of Aβ, GFAP, Iba-1, and Ki-67. However, hippocampal c-Fos staining increased in VSL#3 fed AppNL-G-Fmice.
CONCLUSION: These data demonstrate intestinal dysbiosis in the AppNL-G-Fmouse model of AD. Probiotic VSL#3 feeding altered both serum and brain levels of lactate and acetate in AppNL-G-Fmice correlating with increased expression of the neuronal activity marker, c-Fos.

Entities:  

Keywords:  Alzheimer’s disease; butyrate; gliosis; microbiota; plaques; probiotics; short chain fatty acids

Mesh:

Substances:

Year:  2020        PMID: 32623399      PMCID: PMC8104916          DOI: 10.3233/JAD-200436

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  70 in total

Review 1.  c-Fos as a transcription factor: a stressful (re)view from a functional map.

Authors:  K J Kovács
Journal:  Neurochem Int       Date:  1998-10       Impact factor: 3.921

2.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

Review 3.  Human Gut Microbiota in Health and Alzheimer's Disease.

Authors:  Leszek Szablewski
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.

Authors:  Gunjan Dhawan; Colin K Combs
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

5.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

Review 6.  Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies.

Authors:  Ting-Ting Huang; Jian-Bo Lai; Yan-Li Du; Yi Xu; Lie-Min Ruan; Shao-Hua Hu
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

7.  Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice.

Authors:  Fatemeh Ashrafian; Arefeh Shahriary; Ava Behrouzi; Hamid Reza Moradi; Shahrbanoo Keshavarz Azizi Raftar; Arezou Lari; Shima Hadifar; Rezvan Yaghoubfar; Sara Ahmadi Badi; Shohre Khatami; Farzam Vaziri; Seyed Davar Siadat
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

8.  Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum.

Authors:  Rodrick J Chiodini; Scot E Dowd; William M Chamberlin; Susan Galandiuk; Brian Davis; Angela Glassing
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

Review 9.  From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.

Authors:  G B Rogers; D J Keating; R L Young; M-L Wong; J Licinio; S Wesselingh
Journal:  Mol Psychiatry       Date:  2016-04-19       Impact factor: 15.992

10.  Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study.

Authors:  Friedrich Leblhuber; Kostja Steiner; Burkhard Schuetz; Dietmar Fuchs; Johanna M Gostner
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

View more
  15 in total

Review 1.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

2.  Post-Weaning Treatment with Probiotic Inhibited Stress-Induced Amnesia in Adulthood Rats: The Mediation of GABAergic System and BDNF/c-Fos Signaling Pathways.

Authors:  Kimia Alizadeh; Hamid Moghimi; Ali Golbabaei; Sakineh Alijanpour; Ameneh Rezayof
Journal:  Neurochem Res       Date:  2022-05-26       Impact factor: 4.414

Review 3.  The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes.

Authors:  Anna Winiarska-Mieczan; Ewa Tomaszewska; Janine Donaldson; Karolina Jachimowicz
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

4.  Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer's Disease.

Authors:  Harpreet Kaur; Suba Nookala; Surjeet Singh; Santhosh Mukundan; Kumi Nagamoto-Combs; Colin Kelly Combs
Journal:  Cells       Date:  2021-09-09       Impact factor: 7.666

5.  Probiotics, prebiotics and their role in Alzheimer's disease.

Authors:  Valeria DArgenio; Daniela Sarnataro
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 6.  Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.

Authors:  Umair Shabbir; Muhammad Sajid Arshad; Aysha Sameen; Deog-Hwan Oh
Journal:  Nutrients       Date:  2021-02-21       Impact factor: 5.717

7.  Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease.

Authors:  Simone Baldi; Marta Menicatti; Giulia Nannini; Elena Niccolai; Edda Russo; Federica Ricci; Marco Pallecchi; Francesca Romano; Matteo Pedone; Giovanni Poli; Daniela Renzi; Antonio Taddei; Antonino S Calabrò; Francesco C Stingo; Gianluca Bartolucci; Amedeo Amedei
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

Review 8.  Regulation of common neurological disorders by gut microbial metabolites.

Authors:  Jeongho Park; Chang H Kim
Journal:  Exp Mol Med       Date:  2021-12-02       Impact factor: 8.718

9.  Probiotics for Alzheimer's Disease: A Systematic Review.

Authors:  Ruth Naomi; Hashim Embong; Fezah Othman; Hasanain Faisal Ghazi; Nithiyah Maruthey; Hasnah Bahari
Journal:  Nutrients       Date:  2021-12-22       Impact factor: 5.717

10.  Liver Bile Acid Changes in Mouse Models of Alzheimer's Disease.

Authors:  Harpreet Kaur; Drew Seeger; Svetlana Golovko; Mikhail Golovko; Colin Kelly Combs
Journal:  Int J Mol Sci       Date:  2021-07-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.